Search

everythinglearnresearchcommunity

for

Search:↓

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Thyroid receptor β can help develop new drugs to treat hair loss.

Injection therapies show promise as effective treatments for hair loss.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

α-MSH increases melanin production in moulting hair follicles, while AVT inhibits it.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Different botulinum toxin products and concentrations can effectively reduce sweating, itching, bladder pressure, hair loss, and muscle spasms.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Activating δ-opioid receptors can help hair grow.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

GABAergic steroid precursors reduce ethanol withdrawal symptoms in certain mice.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Neurosteroids help control dopamine responses in the brain.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.